Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas

PHASE3CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

September 7, 2023

Primary Completion Date

November 28, 2024

Study Completion Date

November 28, 2024

Conditions
Brain Tumor, PrimaryBrain Tumor, Recurrent
Interventions
DRUG

Elucirem

Intravenous administration

DRUG

Dotarem

Intravenous administration

Trial Locations (11)

Unknown

Országos Idegtudományi Intézet - Neuroonkológiai és Intracraniá, Budapest

Semmelweis Egyetem - Neurologiai Klinika, Budapest

Debreceni Egyetem, Debrecen

Pecsi Tudomanyegyetem Klinikai Kozpont, Pécs

Ospedale Papa Giovanni XXIII, Bergamo

Ospedale San Raffaele- Neuroradiologia, Milan

IRCCS C.Mondino, Istituto Neurologico Nazionale, Fondazione, Pavia

Policlinico Universitario Agostino Gemelli, Roma

Uniwersyteckie Centrum Kliniczne w Gdansku, Gdansk

Szpital Specjalistyczny im.L.Rydygiera, Krakow

Independent Public Teaching Hospital no 1 Department of Interventional Radiology and Diagnostic Imaging, Lublin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Guerbet

INDUSTRY